The US Food and Drug Administration (FDA) has sent a warning letter to a company selling three unapproved drugs it's advertised as opioid withdrawal treatments. Regulators told EPH Technologies in a ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. NEW YORK — The FDA sent a warning letter to ...
The FDA sent a warning letter to EPH Technologies, accusing it of marketing and selling unapproved drugs. The products are sold under the names Detoxoplex, Sinoplex and Migrenza, and are marketed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results